Research Article
BibTex RIS Cite

Metabolik Sendrom Penceresinden Obezitede Hastalık Yükü

Year 2021, Volume: 10 Issue: 3, 353 - 359, 21.12.2021
https://doi.org/10.47493/abantmedj.877925

Abstract

INTRODUCTION: In terms of quality of life, it was aimed to reveal the relationship between obesity and the presence of metabolic syndrome in prediabetic or normoglycemic people.

METHODS: A total of 159 patients, 18-65 years of age, were included in the study. Body mass index (BMI) values of 30 kg/m² and above were accepted as obesity. Quality of life was evaluated with short form-36 (SF-36).

RESULTS: According to the SF-36 quality of life assessment of all patients; the median values of physical component, mental component and total score were found to be significantly lower in patients with obesity than those without obesity (p=0.006, p=0.040, p=0.009, respectively). In the subgroup analysis of individuals without metabolic syndrome, according to the SF-36 quality of life assessment; the median values of physical component, mental component and total score were similar in patients with obesity compared to those without obesity (p=0.379, p=0.574, p=0.525, respectively).
Similarly, according to the SF-36 quality of life assessment of all patients; the median values of physical component, mental component and total score were found to be significantly lower in patients with MetS than those without MetS (p<0.001, p<0.001, p<0.001, respectively). In the subgroup analysis of individuals with obesity, according to the SF-36 quality of life assessment; the median values of physical component, mental component and total score were similar in patients with MetS compared to those without MetS (p=0.001, p=0.009, p=0.003, respectively).

DISCUSSION and CONCLUSION: Through this study, it has been shown again that the quality of life is reduced in those with obesity. In addition, our findings show that the reduction in the quality of life of patients with obesity mainly points to the presence of MetS.

Supporting Institution

yoktur

Project Number

yoktur

Thanks

yoktur

References

  • Vanleerberghe P, De Witte N, Claes C, et al. The quality of life of older people aging in place: a literature review. Qual Life Res. 2017 Nov;26(11):2899-2907.
  • Gouw VXH, Jiang Y, Seah B, et al. Effectiveness of internal Qigong on quality of life, depressive symptoms and self-efficacy among community-dwelling older adults with chronic disease: A systematic review and meta-analysis. Int J Nurs Stud. 2019 Nov;99:103378.
  • Megari K. Quality of Life in Chronic Disease Patients. Health Psychol Res. 2013 Sep 23;1(3):e27.
  • Sonmez A, Yumuk V, Haymana C, et al. TEMD Study Group. Impact of Obesity on the Metabolic Control of Type 2 Diabetes: Results of the Turkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Obesity Study). Obes Facts. 2019;12(2):167-178.
  • Masmiquel L, Leiter LA, Vidal J, et al. LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial. Cardiovasc Diabetol. 2016 Feb; 15(1): 29.
  • Satman I, Omer B, Tutuncu Y, et al. TURDEP-II Study Group. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013 Feb;28(2):169-80.
  • Payne ME, Porter Starr KN, Orenduff M, et al. Quality of Life and Mental Health in Older Adults with Obesity and Frailty: Associations with a Weight Loss Intervention. J Nutr Health Aging. 2018;22(10):1259-1265.
  • World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: i–xii, 1–253.
  • Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120: 1640-1645.
  • Karlsen TI, Tveitå EK, Natvig GK, et al. Validity of the SF-36 in patients with morbid obesity. Obes Facts. 2011;4(5):346-51.
  • Wee CC, Davis RB, Hamel MB. Comparing the SF-12 and SF-36 health status questionnaires in patients with and without obesity. Health Qual Life Outcomes. 2008;6:11.
  • Singh M, Gupta N, Kumar R. Effect of obesity and metabolic syndrome on severity, quality of life, sleep quality and inflammatory markers in patients of asthma in India. Pneumonol Alergol Pol. 2016;84(5):258-64.
  • Slagter SN, van Vliet-Ostaptchouk JV, van Beek AP, et al. Health-Related Quality of Life in Relation to Obesity Grade, Type 2 Diabetes, Metabolic Syndrome and Inflammation. PLoS One. 2015 Oct 16;10(10):e0140599.
  • Vetter ML, Wadden TA, Lavenberg J, et al. Relation of health-related quality of life to metabolic syndrome, obesity, depression and comorbid illnesses. Int J Obes (Lond). 2011 Aug;35(8):1087-94.
  • Nam SY. Obesity-Related Digestive Diseases and Their Pathophysiology. Gut Liver. 2017 May 15;11(3):323-334.
  • Xu T, Sheng Z, Yao L. Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment. Front Med. 2017 Sep;11(3):340-348.
  • Tremmel M, Gerdtham UG, Nilsson PM, et al. Economic Burden of Obesity: A Systematic Literature Review. Int J Environ Res Public Health. 2017;14(4). pii: E435.

Burden of Disease in Obesity through the Window of Metabolic Syndrome

Year 2021, Volume: 10 Issue: 3, 353 - 359, 21.12.2021
https://doi.org/10.47493/abantmedj.877925

Abstract

INTRODUCTION: In terms of quality of life, it was aimed to reveal the relationship between obesity and the presence of metabolic syndrome in prediabetic or normoglycemic people.

METHODS: A total of 159 patients, 18-65 years of age, were included in the study. Body mass index (BMI) values of 30 kg/m² and above were accepted as obesity. Quality of life was evaluated with short form-36 (SF-36).

RESULTS: According to the SF-36 quality of life assessment of all patients; the median values of physical component, mental component and total score were found to be significantly lower in patients with obesity than those without obesity (p=0.006, p=0.040, p=0.009, respectively). In the subgroup analysis of individuals without metabolic syndrome, according to the SF-36 quality of life assessment; the median values of physical component, mental component and total score were similar in patients with obesity compared to those without obesity (p=0.379, p=0.574, p=0.525, respectively).
Similarly, according to the SF-36 quality of life assessment of all patients; the median values of physical component, mental component and total score were found to be significantly lower in patients with MetS than those without MetS (p<0.001, p<0.001, p<0.001, respectively). In the subgroup analysis of individuals with obesity, according to the SF-36 quality of life assessment; the median values of physical component, mental component and total score were similar in patients with MetS compared to those without MetS (p=0.001, p=0.009, p=0.003, respectively).

DISCUSSION and CONCLUSION: Through this study, it has been shown again that the quality of life is reduced in those with obesity. In addition, our findings show that the reduction in the quality of life of patients with obesity mainly points to the presence of MetS.

Project Number

yoktur

References

  • Vanleerberghe P, De Witte N, Claes C, et al. The quality of life of older people aging in place: a literature review. Qual Life Res. 2017 Nov;26(11):2899-2907.
  • Gouw VXH, Jiang Y, Seah B, et al. Effectiveness of internal Qigong on quality of life, depressive symptoms and self-efficacy among community-dwelling older adults with chronic disease: A systematic review and meta-analysis. Int J Nurs Stud. 2019 Nov;99:103378.
  • Megari K. Quality of Life in Chronic Disease Patients. Health Psychol Res. 2013 Sep 23;1(3):e27.
  • Sonmez A, Yumuk V, Haymana C, et al. TEMD Study Group. Impact of Obesity on the Metabolic Control of Type 2 Diabetes: Results of the Turkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Obesity Study). Obes Facts. 2019;12(2):167-178.
  • Masmiquel L, Leiter LA, Vidal J, et al. LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial. Cardiovasc Diabetol. 2016 Feb; 15(1): 29.
  • Satman I, Omer B, Tutuncu Y, et al. TURDEP-II Study Group. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013 Feb;28(2):169-80.
  • Payne ME, Porter Starr KN, Orenduff M, et al. Quality of Life and Mental Health in Older Adults with Obesity and Frailty: Associations with a Weight Loss Intervention. J Nutr Health Aging. 2018;22(10):1259-1265.
  • World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000; 894: i–xii, 1–253.
  • Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120: 1640-1645.
  • Karlsen TI, Tveitå EK, Natvig GK, et al. Validity of the SF-36 in patients with morbid obesity. Obes Facts. 2011;4(5):346-51.
  • Wee CC, Davis RB, Hamel MB. Comparing the SF-12 and SF-36 health status questionnaires in patients with and without obesity. Health Qual Life Outcomes. 2008;6:11.
  • Singh M, Gupta N, Kumar R. Effect of obesity and metabolic syndrome on severity, quality of life, sleep quality and inflammatory markers in patients of asthma in India. Pneumonol Alergol Pol. 2016;84(5):258-64.
  • Slagter SN, van Vliet-Ostaptchouk JV, van Beek AP, et al. Health-Related Quality of Life in Relation to Obesity Grade, Type 2 Diabetes, Metabolic Syndrome and Inflammation. PLoS One. 2015 Oct 16;10(10):e0140599.
  • Vetter ML, Wadden TA, Lavenberg J, et al. Relation of health-related quality of life to metabolic syndrome, obesity, depression and comorbid illnesses. Int J Obes (Lond). 2011 Aug;35(8):1087-94.
  • Nam SY. Obesity-Related Digestive Diseases and Their Pathophysiology. Gut Liver. 2017 May 15;11(3):323-334.
  • Xu T, Sheng Z, Yao L. Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment. Front Med. 2017 Sep;11(3):340-348.
  • Tremmel M, Gerdtham UG, Nilsson PM, et al. Economic Burden of Obesity: A Systematic Literature Review. Int J Environ Res Public Health. 2017;14(4). pii: E435.
There are 17 citations in total.

Details

Primary Language Turkish
Subjects Clinical Sciences
Journal Section Research Articles
Authors

Ulaş Serkan Topaloğlu 0000-0001-6625-7763

Project Number yoktur
Publication Date December 21, 2021
Submission Date February 10, 2021
Published in Issue Year 2021 Volume: 10 Issue: 3

Cite

APA Topaloğlu, U. S. (2021). Metabolik Sendrom Penceresinden Obezitede Hastalık Yükü. Abant Medical Journal, 10(3), 353-359. https://doi.org/10.47493/abantmedj.877925
AMA Topaloğlu US. Metabolik Sendrom Penceresinden Obezitede Hastalık Yükü. Abant Med J. December 2021;10(3):353-359. doi:10.47493/abantmedj.877925
Chicago Topaloğlu, Ulaş Serkan. “Metabolik Sendrom Penceresinden Obezitede Hastalık Yükü”. Abant Medical Journal 10, no. 3 (December 2021): 353-59. https://doi.org/10.47493/abantmedj.877925.
EndNote Topaloğlu US (December 1, 2021) Metabolik Sendrom Penceresinden Obezitede Hastalık Yükü. Abant Medical Journal 10 3 353–359.
IEEE U. S. Topaloğlu, “Metabolik Sendrom Penceresinden Obezitede Hastalık Yükü”, Abant Med J, vol. 10, no. 3, pp. 353–359, 2021, doi: 10.47493/abantmedj.877925.
ISNAD Topaloğlu, Ulaş Serkan. “Metabolik Sendrom Penceresinden Obezitede Hastalık Yükü”. Abant Medical Journal 10/3 (December 2021), 353-359. https://doi.org/10.47493/abantmedj.877925.
JAMA Topaloğlu US. Metabolik Sendrom Penceresinden Obezitede Hastalık Yükü. Abant Med J. 2021;10:353–359.
MLA Topaloğlu, Ulaş Serkan. “Metabolik Sendrom Penceresinden Obezitede Hastalık Yükü”. Abant Medical Journal, vol. 10, no. 3, 2021, pp. 353-9, doi:10.47493/abantmedj.877925.
Vancouver Topaloğlu US. Metabolik Sendrom Penceresinden Obezitede Hastalık Yükü. Abant Med J. 2021;10(3):353-9.